Foley & Lardner LLP recently represented Cortical Ventures as an investor in a pre-seed funding round for Kyber Labs, which uses novel artificial muscle technology to enable next-generation robotics manipulation platform. Foley represented Cortical Ventures as the lead investor in the pre-seed funding round.
These new funds will fuel Kyber Labs vision for revolutionizing the robotics industry using their innovative artificial muscle by enabling them to expand their team, accelerate product development, and deeply explore markets where their tech can add the most value.
The Foley team was led by partner Louis Lehot and included associates Saige Gallop and Trevor Mullin.
People
Related News
May 14, 2026
Deals and Wins
Foley Advises Carna Health on Partnership with Renalytix to Advance Kidney Disease Management
Foley & Lardner LLP served as intellectual property counsel to Carna Health, an AI-enabled digital health company revolutionizing chronic disease prevention, in its partnership with Renalytix PLC (LSE: RENX) (OTCQB: RNLXY) to advance a novel, integrated approach to chronic kidney disease (CKD) management.
May 8, 2026
Deals and Wins
Foley Advises Kids2 on $225M Credit Facility Led by Bain Capital
Foley & Lardner LLP served as legal advisor to Kids2 in connection with a $225 million senior credit facility to support global growth and expansion for which Bain Capital’s Private Credit Group acted as sole lender and administrative agent.
May 8, 2026
Deals and Wins
Foley Advises Crown Affair in Series C Investment Led by Stride Consumer Partners
Foley & Lardner LLP served as legal advisor to Crown Affair—an emerging luxury haircare brand recognized for its clean, high-performing formulas and emphasis on thoughtful haircare rituals—in its Series C investment led by private equity firm Stride Consumer Partners.